Testosterone Test Kits Market Size, Share and Global Trend by Sample (Blood, Saliva), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy) and Regional Forecast, 2024-2032

According to researchers, one out of four men at the age of 30 suffer from low-level testosterone. The reasons for this lack of testosterone levels may vary due to conditions including testicular injury, infection of the testicles, chronic diseases, genetic diseases, and others. Testosterone is a sex hormone that plays a significant role in sexual and reproductive development in males.

Testosterone fits a class of male hormones called androgens, which are sometimes called steroids or anabolic steroids. Men with low testosterone levels experiences, reduced sexual drive, erectile dysfunction, low sperm count and enlarged or swollen breast tissue. Rising chronic disease such as obesity, liver disease, type 2 diabetes, kidney disease, and human immunodeficiency virus are some factors responsible for the decrease in the testosterone level. This is expected to drive the growth of the testosterone test kits market globally. 

Adoption of a sedentary lifestyle leading to disorders that affect the hormonal balance is responsible for lower or higher levels of testosterone in the body. This, combined with an increasing emphasis on early diagnosis, along with the availability of rapid test kits in the market, will lead to increasing demand for the diagnostics kits, subsequently driving the growth of the global testosterone test kits market from 2019-2026. 

The factor that is expected to inhibit the growth of the market is the lack of accuracy by the saliva test sample kit and the cost of testosterone test kits. 

Key Players Covered 

Some of the major companies that are present in the global testosterone test kits market BioVision Inc., Aviva Systems Biology Corporation, Novus Biologicals, Enzo Life Sciences, Inc., EagleBio, NEOGEN CORPORATION, R&D Systems, Inc., LifeSpan BioSciences, Inc., ARCpoint and other prominent players. 

 SEGMENTATION 

At present, hospital pharmacies have the highest share among the distribution segment. Online stores segment is expected to dominate the market by the end of the forecast period. 

Key Insights 

• Prevalence of diseases being treated by currently approved Testosterone Test Kits in key countries


• The regulatory scenario for key countries


• Reimbursement Scenario for key countries


• Key mergers and acquisitions


• Key start-ups with their funding overview 

Regional Analysis 

Among the regions, North America is expected to dominate the global testosterone test kits market in the forecast period due to the high awareness about the hypogonadism among the citizens and medical practitioners, and major initiatives taken by the government and private organizations towards the investment in the research and development of the faster detection kits. Asia Pacific is anticipated to grow at a significant CAGR, owing to the increasing prevalence of the chronic disease, aging population, and rapidly growing medical infrastructure. 

Key Industry Developments

• In February 2019, Thrive Ltd. launched a saliva-based cortisol stress test and two female hormone kits. The female hormone kit includes a test for Oestradiol, Testosterone, and others.
• In March 2019 Thorne announced the launch of its wide portfolio of home-based tests including tests for weight management, testosterone, and menopause.
• In 2017, Abbkine, Inc. launched EliKine Testosterone ELISA Kit which is suitable for serum, plasma, and other biological fluids to be used specifically by scientific researchers.